CUSIP No. 82846H405
Schedule 13G
Item 1(a). | Name of Issuer: |
QXO, Inc.
Item 1(b). | Address of Issuer’s Principal Executive Offices: |
Five American Lane, Greenwich, CT 06831
Item 2(a) | Name of Persons Filing: |
This statement is being filed by Finepoint Capital LP (“Finepoint”) and Herbert Wagner (each, a “Reporting Person” and together, the “Reporting Persons”). Finepoint is a registered investment adviser to certain affiliated funds (the “Funds”) that directly hold the securities of the Issuer to which this statement relates for the benefit of their respective investors, and in such capacity Finepoint has voting and dispositive power over such securities. Herbert Wagner is the founder of Finepoint and Managing Partner of FPCap LLC, the general partner of Finepoint, and is responsible for the management of the Funds.
The Joint Filing Agreement between the Reporting Persons is attached hereto as Exhibit 1.
Item 2(b) | Address of Principal Business Office: |
For both Reporting Persons: 500 Boylston Street, 24th Floor, Boston, MA 02116
Item 2(c) | Citizenship or Place of Organization: |
Finepoint is a Delaware limited partnership. Herbert Wagner is a citizen of the United States.
Item 2(d) | Title of Class of Securities: |
Common Stock, par value $0.00001 (“Common Stock”)
82846H405
Item 3. | For Statements Filed Pursuant to Rules 13d-1(b), or 13d-2(b) or (c): |
| | | | |
(a) | | ☐ | | Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). |
| | |
(b) | | ☐ | | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). |
| | |
(c) | | ☐ | | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). |
4